España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Protagonist Therapeutics
PTGX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$46.46
4.81
11.55%
At close: -
$45.93
-0.53
-1.14%
After Hours: 5:35 PM EDT
Get Report
Comment
Protagonist Therapeutics (PTGX) Forecast
News
Earnings
Protagonist Therapeutics (PTGX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Protagonist Therapeutics (NASDAQ:PTGX) Stock
Protagonist Therapeutics Stock (NASDAQ: PTGX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 22, 2024
Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk
Thursday, November 21, 2024
Protagonist Selects PN-881 As Development Can...
Benzinga Newsdesk
Tuesday, November 19, 2024
HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk
Wednesday, November 13, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, November 11, 2024
HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk
Thursday, November 07, 2024
Protagonist Therapeutics Q3 EPS $(0.54) Beats...
Benzinga Newsdesk
Tuesday, November 05, 2024
Wedbush Initiates Coverage On Protagonist The...
Benzinga Newsdesk
Tuesday, September 24, 2024
TD Cowen Initiates Coverage On Protagonist Th...
Benzinga Newsdesk
Thursday, September 12, 2024
HC Wainwright & Co. Maintains Buy on Protagon...
Benzinga Newsdesk
Tuesday, September 10, 2024
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
Vandana Singh
Monday, September 09, 2024
Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk
Truist Securities Initiates Coverage On Prota...
Benzinga Newsdesk
Wednesday, August 07, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Protagon...
Benzinga Newsdesk
Tuesday, August 06, 2024
Protagonist Says Cash And Equivalents Of $595...
Benzinga Newsdesk
Protagonist Therapeutics Q2 2024 GAAP EPS $(0...
Benzinga Newsdesk
Protagonist Therapeutics shares are trading l...
Benzinga Newsdesk
Sunday, July 28, 2024
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Lekha Gupta
Thursday, July 25, 2024
JP Morgan Maintains Overweight on Protagonist...
Benzinga Newsdesk
Wednesday, July 24, 2024
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk
BTIG Maintains Buy on Protagonist Therapeutic...
Benzinga Newsdesk
Friday, June 28, 2024
Market-Moving News for June 28th
Benzinga Newsdesk
Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk
Thursday, June 27, 2024
Protagonist Therapeutics To Join S&P SmallCap...
Benzinga Newsdesk
Monday, June 17, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Friday, June 14, 2024
HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk
Protagonist Presents Updated Long-Term Findin...
Benzinga Newsdesk
Tuesday, May 14, 2024
Protagonist Therapeutics Presents Long-Term F...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk
Wednesday, May 08, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Tuesday, May 07, 2024
Protagonist Therapeutics Q1 EPS $3.26, Sales ...
Benzinga Newsdesk
Tuesday, March 26, 2024
Protagonist Therapeutics Has Randomized 241 P...
Benzinga Newsdesk
Monday, March 18, 2024
Protagonist Therapeutics Closes Worldwide Rus...
Benzinga Newsdesk
Monday, March 11, 2024
HC Wainwright & Co. Maintains Buy on Protagon...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Protagonist Therapeutics Announced A Late-bre...
Benzinga Newsdesk
Wednesday, February 28, 2024
JP Morgan Maintains Overweight on Protagonist...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk
Tuesday, February 27, 2024
Protagonist Therapeutics Q4 2023 GAAP EPS $0....
Benzinga Newsdesk
Wednesday, February 21, 2024
Protagonist Therapeutics Publishes Results Of...
Benzinga Newsdesk
Thursday, February 01, 2024
Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk
Why Is Japanese Drugmaker Takeda Stock Trading Lower Today?
Vandana Singh
Wednesday, January 31, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk
Takeda And Protagonist Therapeutics, Inc. Ent...
Benzinga Newsdesk
Wednesday, December 13, 2023
Protagonist Therapeutics Earned $10M Mileston...
Benzinga Newsdesk
Tuesday, December 12, 2023
Protagonist Reports 2-Year Follow Up Data Fro...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch